BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26922130)

  • 1. Brain Natriuretic Peptide and Particular Left Ventricle Segment Asynergy Associated with Cardioembolic Stroke from Old Myocardial Infarction.
    Hosomi N; Yoshimoto T; Kanaya Y; Neshige S; Hara N; Himeno T; Kono R; Takeshima S; Takamatsu K; Ota T; Miyamoto Y; Yasuda K; Shimoe Y; Ota T; Kuriyama M; Matsumoto M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1165-1171. PubMed ID: 26922130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.
    Naya T; Yukiiri K; Hosomi N; Takahashi T; Ohkita H; Mukai M; Koziol JA; Kohno M
    Cerebrovasc Dis; 2008; 26(4):434-40. PubMed ID: 18799875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Dimensional Speckle Tracking Echocardiography Predict Left Ventricular Remodeling after Acute Myocardial Infarction in Patients with Preserved Ejection Fraction.
    Hsiao JF; Chung CM; Chu CM; Lin YS; Pan KL; Chang ST; Hsu JT
    PLoS One; 2016; 11(12):e0168109. PubMed ID: 28033331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
    Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction--contribution of cystatin C assessment.
    Derzhko R; Plaksej R; Przewlocka-Kosmala M; Kosmala W
    Coron Artery Dis; 2009 Nov; 20(7):453-61. PubMed ID: 19741512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early invasive strategy in patients with myocardial infarction and intraventricular conduction disturbances and plasma B-type natriuretic peptide levels assessed 6 months after myocardial infarction].
    Ciuraszkiewicz K; Sielski J; Janion-Sadowska A; Sadowski M; Janion M
    Pol Merkur Lekarski; 2012 May; 32(191):293-7. PubMed ID: 22779334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of ventricular-arterial coupling and B-type natriuretic peptide in patients after myocardial infarction: a five-year follow-up study.
    Antonini-Canterin F; Enache R; Popescu BA; Popescu AC; Ginghina C; Leiballi E; Piazza R; Pavan D; Rubin D; Cappelletti P; Nicolosi GL
    J Am Soc Echocardiogr; 2009 Nov; 22(11):1239-45. PubMed ID: 19783121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
    Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
    Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
    Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
    Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM
    Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Asanin M; Stankovic S; Mrdovic I; Matic D; Savic L; Majkic-Singh N; Ostojic M; Vasiljevic Z
    Peptides; 2012 May; 35(1):74-7. PubMed ID: 22421508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma B-type natriuretic peptide in diagnosing inferior myocardial infarction with right ventricular involvement.
    Kaya MG; Ozdogru I; Kalay N; Dogan A; Inanc T; Gul I; Gunebakmaz O; Oguzhan A
    Coron Artery Dis; 2008 Dec; 19(8):609-13. PubMed ID: 18971785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction.
    Cerisano G; Pucci PD; Valenti R; Boddi V; Migliorini A; Tommasi MS; Raspanti S; Parodi G; Antoniucci D
    Am J Cardiol; 2005 Apr; 95(8):930-4. PubMed ID: 15820157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
    Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
    Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.